Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Form 8.5 (EPT/RI)

21 May 2010 15:32

RNS Number : 3693M
Credit Suisse Securities (Eur) Ltd
21 May 2010
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Credit Suisse Securities (Europe) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Ark Therapeutics Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Ark Therapeutics Group Plc

(d) Date dealing undertaken:

20-May-2010

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary shares

Purchase

Β 

60,000

0.085 (GBP)

0.08 (GBP)

Ordinary shares

Sales

Β 

60,000

0.085 (GBP)

0.08 (GBP)

Β (b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Date of disclosure:

21-May-2010

Contact name:

Carolyn Collins/Simon Crawley

Telephone number:

0207 888 0241

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FERBSGDUGXDBGGB
Date   Source Headline
8th Jun 20078:00 amRNSBlocklisting Interim Review
8th Jun 20078:00 amRNSBlocklisting Interim Review
7th Jun 20077:00 amRNSKerraped Launch
31st May 200710:13 amRNSVoting Rights and Capital
31st May 20077:02 amRNSResearch Update
22nd May 20077:01 amRNSTrinam Update
2nd May 20077:01 amRNSTrinam(R) RAC Application
30th Apr 20074:10 pmRNSVoting Rights and Capital
27th Apr 20077:01 amRNSRegulatory Update
26th Apr 20075:29 pmRNSResult of AGM
24th Apr 20077:01 amRNSResearch Update
2nd Apr 20071:42 pmRNSVoting Rights and Capital
2nd Apr 200712:22 pmRNSAnnual Information Update
30th Mar 20071:57 pmRNSHolding(s) in Company
19th Mar 20072:20 pmRNSBlock Listing Application
15th Mar 20075:37 pmRNSHolding(s) in Company
12th Mar 20072:12 pmRNSHolding(s) in Company
7th Mar 20077:01 amRNSFinal Results
5th Mar 20075:33 pmRNSHolding(s) in Company
1st Mar 200710:40 amRNSVoting Rights and Capital
23rd Feb 20079:00 amRNSHolding(s) in Company
22nd Feb 20077:01 amRNSStroke Patent
16th Feb 20079:00 amRNSHolding(s) in Company
16th Feb 20077:00 amRNSResearch Update
6th Feb 20071:03 pmRNSHolding(s) in Company
5th Feb 20072:41 pmRNSOption Awards
1st Feb 20077:01 amRNSEuropean Grant Awarded
25th Jan 20075:19 pmRNSHolding(s) in Company
22nd Jan 200711:24 amRNSTotal Voting Rights
19th Jan 200712:28 pmRNSNotice of Results
15th Jan 200712:45 pmRNSRe: Award
11th Jan 20077:01 amRNSResearch Update
5th Jan 20077:53 amRNSResearch Update
20th Dec 20062:00 pmRNSHolding(s) in Company
20th Dec 200610:28 amRNSVoting and Rights Capital
18th Dec 20067:01 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSPlacing of Shares
4th Dec 200611:26 amRNSBlocklisting Interim Review
4th Dec 200611:21 amRNSBlocklisting Interim Review
27th Nov 20061:44 pmRNSHolding(s) in Company
13th Oct 20067:00 amRNSCerepro Patent Granted
10th Oct 20067:01 amRNSRe: Kerraboot
2nd Oct 20063:49 pmRNSHolding(s) in Company
27th Sep 20067:01 amRNSResearch Update
8th Sep 20064:11 pmRNSHolding(s) in Company
5th Sep 20067:03 amRNSResearch Update
1st Sep 20067:00 amRNSCerepro EMEA review
30th Aug 20067:01 amRNSInterim Results
23rd Aug 20067:01 amRNSResearch Update
4th Aug 200612:50 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.